Global Gene Therapy Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Gene Therapy market size will reach 15,574 Million USD in 2025 and is projected to reach 76,411 Million USD by 2032, with a CAGR of 25.51% (2025-2032). Notably, the China Gene Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Gene therapy is a therapeutic approach that involves the introduction, modification, or replacement of genetic material within an individual＇s cells to treat or prevent diseases. This innovative field aims to address the underlying genetic causes of various disorders, including genetic diseases, certain types of cancer, and other conditions with a genetic component. Gene therapy can be achieved by delivering therapeutic genes using viral vectors or non-viral methods to target cells, correcting genetic mutations, enhancing or suppressing gene expression, or introducing entirely new genetic material. In the context of genetic diseases, gene therapy seeks to provide functional copies of missing or defective genes, restoring normal cellular function. The field has shown particular promise in treating certain genetic disorders, such as cystic fibrosis and some types of inherited blindness. Ongoing research and clinical trials continue to expand the applications of gene therapy, offering potential breakthroughs in the treatment of a wide range of diseases.
The major global suppliers of Gene Therapy include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, AnGes, SIBIONO, Orchard Therapeutics, Human Stem Cells Institute, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gene Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Gene Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gene Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Gene Therapy Include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
AnGes
SIBIONO
Orchard Therapeutics
Human Stem Cells Institute
Gene Therapy Product Segment Include:
Viral Gene Therapy
Non-Viral Gene Therapy
Gene Therapy Product Application Include:
Neurological Diseases
Cancer
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gene Therapy Industry PESTEL Analysis
Chapter 3: Global Gene Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Gene Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Gene Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Gene Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gene Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Gene Therapy market size will reach 15,574 Million USD in 2025 and is projected to reach 76,411 Million USD by 2032, with a CAGR of 25.51% (2025-2032). Notably, the China Gene Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Gene therapy is a therapeutic approach that involves the introduction, modification, or replacement of genetic material within an individual＇s cells to treat or prevent diseases. This innovative field aims to address the underlying genetic causes of various disorders, including genetic diseases, certain types of cancer, and other conditions with a genetic component. Gene therapy can be achieved by delivering therapeutic genes using viral vectors or non-viral methods to target cells, correcting genetic mutations, enhancing or suppressing gene expression, or introducing entirely new genetic material. In the context of genetic diseases, gene therapy seeks to provide functional copies of missing or defective genes, restoring normal cellular function. The field has shown particular promise in treating certain genetic disorders, such as cystic fibrosis and some types of inherited blindness. Ongoing research and clinical trials continue to expand the applications of gene therapy, offering potential breakthroughs in the treatment of a wide range of diseases.
The major global suppliers of Gene Therapy include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, AnGes, SIBIONO, Orchard Therapeutics, Human Stem Cells Institute, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gene Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Gene Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gene Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Gene Therapy Include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
AnGes
SIBIONO
Orchard Therapeutics
Human Stem Cells Institute
Gene Therapy Product Segment Include:
Viral Gene Therapy
Non-Viral Gene Therapy
Gene Therapy Product Application Include:
Neurological Diseases
Cancer
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gene Therapy Industry PESTEL Analysis
Chapter 3: Global Gene Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Gene Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Gene Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Gene Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gene Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Gene Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gene Therapy Product by Type
- 1.2.1 Viral Gene Therapy
- 1.2.2 Non-Viral Gene Therapy
- 1.3 Gene Therapy Product by Application
- 1.3.1 Neurological Diseases
- 1.3.2 Cancer
- 1.3.3 Other
- 1.4 Global Gene Therapy Market Size Analysis (2020-2032)
- 1.5 Gene Therapy Market Development Status and Trends
- 1.5.1 Gene Therapy Industry Development Status Analysis
- 1.5.2 Gene Therapy Industry Development Trends Analysis
- 2 Gene Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gene Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gene Therapy Market Analysis by Country
- 4.1 Global Gene Therapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Gene Therapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Gene Therapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Gene Therapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Gene Therapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 Gene Therapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Gene Therapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Gene Therapy Market Analysis by Type
- 6.1 Global Gene Therapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Gene Therapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Biogen
- 7.1.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Biogen Gene Therapy Product Portfolio
- 7.1.3 Biogen Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Novartis
- 7.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Novartis Gene Therapy Product Portfolio
- 7.2.3 Novartis Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Gilead Sciences
- 7.3.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Gilead Sciences Gene Therapy Product Portfolio
- 7.3.3 Gilead Sciences Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Sarepta Therapeutics
- 7.4.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Sarepta Therapeutics Gene Therapy Product Portfolio
- 7.4.3 Sarepta Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Alnylam Pharmaceuticals
- 7.5.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Alnylam Pharmaceuticals Gene Therapy Product Portfolio
- 7.5.3 Alnylam Pharmaceuticals Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Amgen
- 7.6.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Amgen Gene Therapy Product Portfolio
- 7.6.3 Amgen Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Spark Therapeutics
- 7.7.1 Spark Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Spark Therapeutics Gene Therapy Product Portfolio
- 7.7.3 Spark Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Akcea Therapeutics
- 7.8.1 Akcea Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Akcea Therapeutics Gene Therapy Product Portfolio
- 7.8.3 Akcea Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 bluebird bio
- 7.9.1 bluebird bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 bluebird bio Gene Therapy Product Portfolio
- 7.9.3 bluebird bio Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Sunway Biotech
- 7.10.1 Sunway Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Sunway Biotech Gene Therapy Product Portfolio
- 7.10.3 Sunway Biotech Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 AnGes
- 7.11.1 AnGes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 AnGes Gene Therapy Product Portfolio
- 7.11.3 AnGes Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 SIBIONO
- 7.12.1 SIBIONO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 SIBIONO Gene Therapy Product Portfolio
- 7.12.3 SIBIONO Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Orchard Therapeutics
- 7.13.1 Orchard Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Orchard Therapeutics Gene Therapy Product Portfolio
- 7.13.3 Orchard Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Human Stem Cells Institute
- 7.14.1 Human Stem Cells Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Human Stem Cells Institute Gene Therapy Product Portfolio
- 7.14.3 Human Stem Cells Institute Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Gene Therapy Industry Chain Analysis
- 8.2 Gene Therapy Product Downstream Application Analysis
- 8.2.1 Global Gene Therapy Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Gene Therapy Revenue and Forecast by Application (2020-2032)
- 8.3 Gene Therapy Typical Downstream Customers
- 8.4 Gene Therapy Sales Channel Analysis
- <
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
